Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 2021-05-23 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| -0.58% | +0.43% | +31.09% | -4.81% | 78.83B | |
| -2.55% | +6.99% | +505.27% | +47.92% | 63.11B | |
| -1.11% | +5.08% | -11.47% | -33.91% | 60.48B | |
| +0.14% | -1.20% | -11.64% | +24.21% | 46.75B | |
| -0.24% | +1.22% | +2.26% | +151.03% | 45.66B | |
| -1.62% | -0.76% | +49.85% | -14.92% | 32.37B | |
| -1.81% | +3.16% | +45.71% | +110.57% | 25.87B | |
| +0.47% | +3.26% | -0.77% | +142.41% | 21.33B | |
| +0.27% | +1.96% | +62.19% | +102.81% | 15.8B | |
| Average | -0.70% | +1.97% | +74.72% | +58.37% | 43.35B | |
| Weighted average by Cap. | -0.93% | +2.23% | +94.73% | +40.14% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.91M 2.75M 2.5M 4.68M 320M 4.7M 32.93M 12.71M 163M 12.54M 12.26M 524M | 6.18M 5.39M 5.09M 4.62M 8.66M 593M 8.69M 60.95M 23.52M 301M 23.21M 22.7M 970M |
| Net income | 1.4M 1.22M 1.15M 1.05M 1.96M 135M 1.97M 13.83M 5.34M 68.42M 5.27M 5.15M 220M | 2.41M 2.1M 1.98M 1.8M 3.38M 231M 3.39M 23.77M 9.17M 118M 9.05M 8.85M 378M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
